Citations

Showing 10 of 108083 citations.

Younger Matched Unrelated Donors Confer a Decreased Relapse Risk As Compared to Older Sibling Donors for Adult B-Cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Estrada‐Merly, Noel, Zhang, Mei‐Jie , Chen, Karen , Bredeson, Christopher , Litzow, Mark R. , Saber, Wael , Abid, Muhammad Bilal , Allan, David , Sabloff, Mitchell , Kebriaei, Partow

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10540-10541

10.1182/blood-2022-163517 Get It

A Comparison of Financial Hardship Among Survivors of Childhood Cancer Treated with and without Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study
Buchbinder, David , Wang, Huiqi , Huang, I‐Chan , Yabroff, K. Robin , Khera, Nandita , Yabroff, K Robin , Bhatt, Neel S. , Yasui, Yutaka , Armenian, Saro H. , Bhatia, Smita , Chow, Eric J. , Kirchhoff, Anne C. , Leisenring, Wendy M. , Armstrong, Gregory T. , Nathan, Paul C.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10981-10982

10.1182/blood-2022-159132 Get It

Optimal Sequencing Determination in Relapsed Multiple Myeloma
Sengsayadeth, Salyka, Fitzgerald, Bridget, Nandakumar, Bharat , Schmidt, Timothy M. , Silbermann, Rebecca , Chen, Heidi , Kumar, Shaji , Thapa, Bicky , Chhabra, Saurabh , Callander, Natalie S. , Costa, Luciano J.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10033-10035

10.1182/blood-2022-169589 Get It

Chronic kidney disease is associated with increased all‐cause mortality in transvenous lead extraction: A systematic review and meta‐analysis
Tan, Min Choon , Talaei, Fahimeh , Trongtorsak, Angkawipa , Lee, Justin Z. , Rattanawong, Pattara , Tan, Min C , Rattanawong, Pattara

Mayo Clinic

Pacing and Clinical Electrophysiology | November 28, 2022 | Volume: 46 | Issue: 1 | Pages: 66-72

10.1111/pace.14631 | PMID 36441922 Get It

AbstractBackgroundThe impact of chronic kidney disease (CKD) or end‐stage renal disease (ESRD) on patients receiving transvenous lead extraction (TLE) is not well‐established. We performed a systematic review and meta‐analysis to explore the association between CKD and all‐cause mortality in TLE.MethodsWe searched the databases of PubMed and EMBASE from inception to April 2022. Included studies were published TLE studies that compared the risk of mortality in CKD patients compared to control patients. Data from each study were combined using the random‐effects model.ResultsEight studies (5,013 patients) were included. Compared with controls, CKD patients had a significantly higher risk of overall all‐cause mortality (hazard ratio [HR] = 2.14, 95% confidence interval [CI]: 1.65–2.77, I2 = 51.1%, p < .001). The risk of overall all‐cause mortality increased with the severity of CKD for nonspecific CKD (HR = 2.01, 95% CI: 1.49–2.69, I2 = 53.4, p < .001) and ESRD (HR = 2.79, 95% CI: 1.85–4.23, I2 = 0%, p < .001). The risk of all‐cause mortality in CKD is double at follow‐up ≤1 year (HR = 1.99, 95% CI: 1.29–3.09, I2 = 50.9%, p = .002) and higher at follow‐up >1 year (HR = 2.36, 95% CI: 1.63–3.42, I2 = 59.7%, p < .001).ConclusionsOur meta‐analysis demonstrates a significantly increased risk of overall all‐cause mortality in patients with CKD who underwent TLE compared to controls.
High Prevalence of Epigenetic Mutations in Histiocytic and Dendritic Cell Disorders: Results from Molecular Analysis of a Large Cohort from Histiocytosis Working Group
Abeykoon, Jithma P., Medina, Aldo Acosta, Zanwar, Saurabh , Ruan, Gordon, Jiang, Liuyan , Gruber, Lucinda , Davidge‐Pitts, Caroline , Wu, Xiaosheng , McNinch, Colton M, Dasari, Surendra , Goyal, Gaurav , Abeykoon, Jithma P. , Rech, Karen L. , Ravindran, Aishwarya , Koster, Matthew J. , Tobin, W. Oliver , Vassallo, Robert , Ryu, Jay H. , Bennani, N. Nora , Shah, Meera , Young, Jason R. , McNinch, Colton M, Go, Ronald S.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 32-33

10.1182/blood-2022-162855 Get It

Randomized Phase 2 Trial of First-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma ECOG-ACRIN E1411
Parekh, Samir , Yang, David T. , Kostakoğlu, Lale , Baghdadi, Tareq Al, Maddocks, Kami J. , Romer, Mark D., Inwards, David J. , Lerner, Rachel E. , Little, Richard F. , Friedberg, Jonathan W. , Leonard, John P. , Parekh, Samir , Smith, Mitchell R. , Jegede, Opeyemi A. , Martin, Peter, Till, Brian G. , Casulo, Carla , Bartlett, Nancy L. , Caimi, Paolo F. , Wagner, Lynne I. , Kahl, Brad S.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 186-188

10.1182/blood-2022-170381 Get It

Development and Validation of the advanced-Stage Hodgkin Lymphoma (HL) International Prognostication Index (A-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium
Rodday, Angie Mae , Friedberg, Jonathan W. , Gallamini, Andrea , Upshaw, Jenica , Evens, Andrew M. , Evens, Andrew M , Parsons, Susan K. , Hawkes, Eliza A. , Hodgson, David , Johnson, Peter , Link, Brian K. , Mou, Eric , Savage, Kerry J. , Zinzani, Pier Luigi , Maurer, Matthew J.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 760-762

10.1182/blood-2022-164720 Get It

The Use of Liquid Tranexamic Acid for Pediatric Patients with Bleeding Disorders
Al‐Huniti, Ahmad , Kuhn, Alexis Katherine, Marshall, Linda, Rusk, Dawn, Pruthi, Rajiv K. , Kuhn, Alexis , Ferdjallah, Asmaa

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2720-2721

10.1182/blood-2022-168209 Get It